Wang, H., Cui, G., Cheng, M., Aji, T., Li, G., Hu, X., . . . Ren, Z. (2025). Real‐world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19. Signal Transduction and Targeted Therapy, 10(1), 1. https://doi.org/10.1038/s41392-025-02126-w
Chicago-referens (17:e uppl.)Wang, Haiyu, et al. "Real‐world Effectiveness and Safety of Oral Azvudine Versus Nirmatrelvir‒ritonavir (Paxlovid) in Hospitalized Patients with COVID-19." Signal Transduction and Targeted Therapy 10, no. 1 (2025): 1. https://doi.org/10.1038/s41392-025-02126-w.
MLA-referens (9:e uppl.)Wang, Haiyu, et al. "Real‐world Effectiveness and Safety of Oral Azvudine Versus Nirmatrelvir‒ritonavir (Paxlovid) in Hospitalized Patients with COVID-19." Signal Transduction and Targeted Therapy, vol. 10, no. 1, 2025, p. 1, https://doi.org/10.1038/s41392-025-02126-w.
